Exotic antivenoms for NHS for emergency use

A Contract Award Notice
by PUBLIC HEALTH ENGLAND

Source
Contracts Finder
Type
Contract (Products)
Duration
2 year
Value
£309K-£309K
Sector
HEALTH
Published
02 Jun 2021
Delivery
01 Apr 2021 to 31 Mar 2023
Deadline
31 Mar 2021 00:00

Concepts

Location

Geochart for 1 buyers and 11 suppliers

1 buyer

11 suppliers

Description

Public Health England (PHE) is responsible for the provision of public health stocks of exotic antivenoms for NHS emergency use in the UK. The antivenoms are used in the event of someone being bitten or stung by an exotic venomous animal.

Award Detail

1 South African Vaccine Producers (Sandringham)
  • Value: £309,174
2 Instituto Clodomiro Picado Universidad de Costa Rica (Costa Rica)
  • Value: £309,174
3 Micropharm (None)
  • Value: £309,174
4 National Antivenom & Vaccine Production Centre (None)
  • Value: £309,174
5 Razi Vaccine & Serum Research Institute (Kraj)
  • Value: £309,174
6 Haffkine Biopharmaceutical Corp (Mumbai)
  • Value: £309,174
7 Queen Saovabha Memorial Institute (Bangkok)
  • Value: £309,174
8 Centers for Disease Control (Taipei City)
  • Value: £309,174
9 Seqirus (Victoria)
  • Value: £309,174
10 Instituto Butantan (None)
  • Value: £309,174
11 Serb Labo (None)
  • Value: £309,174

CPV Codes

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

Indicators

  • Contract is suitable for SMEs.

Other Information

This requirement is to source 24 different highly specialist exotic antivenoms from national and international Suppliers. As there are 11 different suppliers for this purchase, each of whom supplies a very small volume of antivenoms, Public Health England will communicate with suppliers and place orders following an exchange of e-mails with the supplier to confirm price per dose, shelf life and delivery timescales. The UK hub sites based across the country are required to hold specified minimum volume on likely treatment dosage. This allows delivery to be made within 5 hours (best endeavours) from when the request is received to any hospital location within the UK. This contract is being awarded under Reg 32(2)(b)(ii). The total contract value specified per supplier cannot be confirmed, as this is dependant on different expiry date of stocks held across various sites across UK. Additionally, the selection of each antivenom will be based on the opinion of the Advisory Group. ECM_8246 - PO terms and conditions.ND PO Terms and Conditions 03.06.16.pdf

Reference

Domains